You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
The correlation between FGF-21 and metabolic effect in patients with bipolar disorder
- In: Poster presentation
- At: Buenos Aires (Argentina) (2016)
- Type: Poster
- Poster code: POS-TRI-003
- By: CHANG, Hui Hua (National Cheng Kung University, Institute of Clinical Pharmacy and Pharmaceutical Sciences, Tainan, China Taiwan)
- Co-author(s): Hui Hua Chang:Institute of Clinical Pharmacy and Pharmaceutical Sciences,National Cheng Kung University,Tainan,Taiwan, Province of China|Yung Wen Cheng:Institute of Clinical Pharmacy and Pharmaceutical Sciences,National Cheng Kung University,Tainan,Taiwan, Province of China|Po Wu Gean:Department of Pharmacology,National Cheng Kung University,Tainan,Taiwan, Province of China|Po See Chen:Department of Psychiatry,National Cheng Kung University,Tainan,Taiwan, Province of China
- Abstract:
Fibroblast growth factor-21 (FGF-21) is a novel endogenous regulator of glucose and lipid metabolism. Recent report indicated that FGF-21 is also a mediator of the neuroprotective effects of mood stabilizers in animal study. In addition, patients with bipolar disorder (BD) had high risk of metabolic abnormalities, but the role of FGF-21 in BD..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026